206 related articles for article (PubMed ID: 12802278)
1. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
Yang HS; Knies JL; Stark C; Colburn NH
Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
[TBL] [Abstract][Full Text] [Related]
2. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
[TBL] [Abstract][Full Text] [Related]
3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
4. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
5. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
7. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
[TBL] [Abstract][Full Text] [Related]
9. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol).
Li S; Ouyang Y; Yang GH; Pestka JJ
Toxicol Appl Pharmacol; 2000 Feb; 163(1):17-25. PubMed ID: 10662601
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model.
Urakami S; Tsuchiya H; Orimoto K; Kobayashi T; Igawa M; Hino O
Biochem Biophys Res Commun; 1997 Dec; 241(1):24-30. PubMed ID: 9405228
[TBL] [Abstract][Full Text] [Related]
12. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
14. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
15. PDCD4 inhibits the malignant phenotype of ovarian cancer cells.
Wei ZT; Zhang X; Wang XY; Gao F; Zhou CJ; Zhu FL; Wang Q; Gao Q; Ma CH; Sun WS; Fu QZ; Chen YH; Zhang LN
Cancer Sci; 2009 Aug; 100(8):1408-13. PubMed ID: 19493270
[TBL] [Abstract][Full Text] [Related]
16. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun.
Bitomsky N; Böhm M; Klempnauer KH
Oncogene; 2004 Sep; 23(45):7484-93. PubMed ID: 15334056
[TBL] [Abstract][Full Text] [Related]
17. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes.
Finch S; Joseloff E; Bowden T
J Cancer Res Clin Oncol; 2002 Jan; 128(1):3-10. PubMed ID: 11862466
[TBL] [Abstract][Full Text] [Related]
18. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice.
Hwang SK; Jin H; Kwon JT; Chang SH; Kim TH; Cho CS; Lee KH; Young MR; Colburn NH; Beck GR; Yang HS; Cho MH
Gene Ther; 2007 Sep; 14(18):1353-61. PubMed ID: 17611588
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
20. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]